EUVIMEDEUVIMED entdecken
Open Access

Macrophage-mimicking nanodiscs for treating systemic infection caused by methicillin-resistant Staphylococcus aureus

Kailin Feng iD, Lei Sun, Zhidong Zhou iD, Jiayuan Alex Zhang, Ronnie H Fang iD, Weiwei Gao iD, Liangfang Zhang iD

Science Advances · 04.07.2025 · 11 (27)

DOI: 10.1126/sciadv.adw7511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 04.07.2025. Verfasst von Kailin Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San …. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Macrophages, Anti-Bacterial Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic-resistant bacteria represent a critical public health challenge, underscoring the urgent need for innovative therapeutic strategies. Inspired by the unique properties of cell membrane–derived nanodiscs, particularly their ultrasmall size and intrinsic membrane functions, we develop macrophage membrane–derived nanodiscs (denoted “MФ-NDs”) as a nanomedicine for the treatment of systemic bacterial infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Our findings demonstrate that MФ-NDs interact directly with bacteria, disrupting their membranes, inducing leakage of intracellular contents, and ultimately causing bacterial death. Meanwhile, MФ-NDs reduce intracellular bacterial count. In a mouse model of systemic MRSA infection, treatment with MФ-NDs significantly improves survival rates in both therapeutic and preventative contexts. Moreover, MФ-NDs show a lower propensity to induce bacterial resistance compared to conventional small-molecule antibiotics. No acute toxicity is observed in mice treated with MФ-NDs. Overall, this study underscores the straightforward fabrication and promising potential of MФ-NDs for addressing antibiotic-resistant bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsMacrophagesAnti-Bacterial AgentsNanostructuresAnimalsMiceDisease Models, AnimalHumansMicrobial Sensitivity TestsCell Membrane

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, La Jolla, CA 92093, USA.

ORCID-Profile: Kailin Feng, Zhidong Zhou, Ronnie H Fang, Weiwei Gao, Liangfang Zhang

Zitieren

APA

Feng, K., Sun, L., Zhou, Z., Zhang, J. A., Fang, R. H., Gao, W., & Zhang, L. (2025). Macrophage-mimicking nanodiscs for treating systemic infection caused by methicillin-resistant Staphylococcus aureus. Science Advances, 11(27). https://doi.org/10.1126/sciadv.adw7511

Vancouver

Feng K, Sun L, Zhou Z, Zhang JA, Fang RH, Gao W, et al. Macrophage-mimicking nanodiscs for treating systemic infection caused by methicillin-resistant Staphylococcus aureus. Science Advances. 2025;11(27). doi:10.1126/sciadv.adw7511

BibTeX
@article{Feng2025,
  author = {Feng, Kailin and Sun, Lei and Zhou, Zhidong and Zhang, Jiayuan Alex and Fang, Ronnie H and Gao, Weiwei and Zhang, Liangfang},
  title = {Macrophage-mimicking nanodiscs for treating systemic infection caused by methicillin-resistant Staphylococcus aureus},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {27},
  doi = {10.1126/sciadv.adw7511}
}
Kostenlos starten →